pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
autogene cevumeran
Solid Tumor
Genentech Inc
0
catalysts
Phase 2
avenciguat
Systemic Sclerosis (Scleroderma)
Boehringer Ingelheim International GmbH
0
catalysts
Phase 2
avicursen
avicursen [INN]
Relapsing Remitting Multiple Sclerosis (RRMS)
Percheron Therapeutics Ltd
0
catalysts
Phase 2
aviptadil
← prev
page 33 of 53
next →
131
Pain
89
Neurology
1
Acute Respiratory Distress Syndrome
Adrenergic receptor alpha
$RLFTY
MindMaze Therapeutics Holding SA
0
catalysts
Phase 2
avoplacel
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
$PLUR
Pluri Inc.
0
catalysts
Phase 2
axelopran
Opioid-Induced Constipation (OIC)
Mu-type opioid receptor
$TBPH
Theravance Biopharma, Inc.
0
catalysts
Phase 2
azacitidine
Vidaza (azacitidine)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
DNA (cytosine-5)-methyltransferase 1
DNA (cytosine-5)-methyltransferase 3A
Bristol-Myers Squibb Co
0
catalysts
Phase 2
azenosertib
azenosertib [INN]
Endometrial Cancer
$ZNTL
Zentalis Pharmaceuticals, Inc.
0
catalysts
Phase 2
azerutamig
azerutamig [INN]
Esophageal Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 2
bafisontamab
Bile Duct Cancer (Cholangiocarcinoma)
Epidermal growth factor receptor
Hepatocyte growth factor receptor
EpimAb Biotherapeutics Inc
0
catalysts
Phase 2
balstilimab
Metastatic Colorectal Cancer
Programmed cell death protein 1
$AGEN
AGENUS INC
0
catalysts
Phase 2
batoclimab
batoclimab [INN]
Graves Diseases
$IMVT
Immunovant, Inc.
0
catalysts
Phase 2
beclomethasone dipropionate
Beclomethasone Dipropionate (beclomethasone dipropionate)
Crohn's Disease (Regional Enteritis)
Glucocorticoid receptor
$SNGX
SOLIGENIX, INC.
0
catalysts
Phase 2
bedoradrine sulfate
Asthma
Beta-2 adrenergic receptor
$MNOV
MEDICINOVA INC
0
catalysts
Phase 2
befiradol
befiradol [INN]
Drug-Induced Dyskinesia
Neurolixis Inc
0
catalysts
Phase 2
belacabnagene franleucel
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis)
$NKTX
Nkarta, Inc.
0
catalysts
Phase 2
bemcentinib
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Oncoinvent ASA
0
catalysts
Phase 2
bempikibart
Alopecia Areata
$QTTB
Q32 Bio Inc.
0
catalysts
Phase 2
benserazide hydrochloride
Beta Thalassaemia
Aromatic-L-amino-acid decarboxylase
Phoenicia Biosciences Inc
0
catalysts
Phase 2
benzalkonium chloride + polyhexanide
benzalkonium chloride [INN] + polyhexanide [INN]
Onychomycosis (Tinea Unguium)
$TTRX
Turn Therapeutics Inc.
0
catalysts
Phase 2
beperminogene perplasmid
Collategene (beperminogene perplasmid [INN])
Arteriosclerosis
AnGes Inc
0
catalysts
Phase 2
bepranemab
Alzheimer's Disease
Microtubule-associated protein tau
UCB SA
0
catalysts
Phase 2
berberine ursodeoxycholate
Primary Sclerosing Cholangitis
HighTide Therapeutics Inc
0
catalysts
Phase 2
beroterkib
Solid Tumor
$MOS
MOSAIC CO
0
catalysts
Phase 2
bersiporocin
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co Ltd
0
catalysts
Phase 2
betahistine dihydrochloride
Vertigo
$CYTOF
Altamira Therapeutics Ltd.
0
catalysts
Phase 2
betamethasone
Keratoconjunctivitis Sicca (Dry Eye)
Glucocorticoid receptor
Surface Ophthalmics Inc
0
catalysts
Phase 2
bexmarilimab
Clevegen (bexmarilimab [INN])
Refractory Acute Myeloid Leukemia
Faron Pharmaceuticals Oy
0
catalysts
Phase 2
bexotegrast
Primary Sclerosing Cholangitis
$PLRX
PLIANT THERAPEUTICS, INC.
0
catalysts
Phase 2
bintrafusp alfa
Bile Duct Cancer (Cholangiocarcinoma)
Programmed cell death 1 ligand 1
Transforming growth factor beta
Merck KGaA
0
catalysts